Becton Dickinson 

$201.91
681
-$1.57-0.77% Today

Statistics

Day High
203.61
Day Low
201.19
52W High
251.99
52W Low
162.29
Volume
1,307,108
Avg. Volume
2,183,460
Mkt Cap
57.63B
P/E Ratio
32.67
Dividend Yield
2.06%
Dividend
4.17

Upcoming

Dividends

2.06%Dividend Yield
Dec 25
$1.05
Sep 25
$1.04
Jun 25
$1.04
Mar 25
$1.04
Dec 24
$1.04
10Y Growth
4.48%
5Y Growth
4.56%
3Y Growth
4.5%
1Y Growth
0.72%

Earnings

9FebExpected
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Next
2.81
3.19
3.58
3.96
Expected EPS
2.8121
Actual EPS
N/A

Financials

7.68%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
43.68BRevenue
3.36BNet Income

Analyst Ratings

$202.67Average Price Target
The highest estimate is 215.00.
From 6 ratings within the last 6 months. This is not an investment recommendation.
Buy
33%
Hold
67%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BDX. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap116.33B
Medtronic competes directly with Becton Dickinson in the medical devices sector, particularly in areas like surgical instruments and diabetes care products.
Abbott Laboratories
ABT
Mkt Cap214.96B
Abbott Laboratories offers a wide range of medical devices, diagnostics, and nutritional products that compete with Becton Dickinson's offerings.
Thermo Fisher Scientific
TMO
Mkt Cap214.25B
Thermo Fisher Scientific competes in the supply of laboratory equipment and consumables, directly challenging Becton Dickinson's life sciences segment.
Danaher
DHR
Mkt Cap152.13B
Danaher Corporation's life sciences and diagnostics divisions offer products that compete with Becton Dickinson's portfolio, especially in diagnostics and research.
Stryker
SYK
Mkt Cap136.19B
Stryker Corporation is a competitor in the medical technology field, particularly in surgical equipment and hospital beds, areas where Becton Dickinson also operates.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific Corporation competes with Becton Dickinson in the medical devices market, especially in areas like cardiovascular and endoscopy products.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson's medical devices division offers products that compete across several of Becton Dickinson's key areas, including surgical instruments and infection prevention.
Hologic
HOLX
Mkt Cap16.45B
Hologic, Inc. competes with Becton Dickinson in the diagnostics and women's health sectors, offering similar products for cancer detection and surgical procedures.
Zimmer Biomet
ZBH
Mkt Cap19.92B
Zimmer Biomet Holdings, Inc. competes in the musculoskeletal healthcare sector, which overlaps with Becton Dickinson's solutions for surgical and rehabilitation products.
Intuitive Surgical
ISRG
Mkt Cap189.4B
Intuitive Surgical, Inc. competes with Becton Dickinson in the surgical instruments market, particularly with its robotic-assisted surgical systems.

About

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Show more...
CEO
Mr. Thomas E. Polen Jr.
Employees
70000
Country
US
ISIN
US0758871091

Listings

0 Comments

Share your thoughts

FAQ

What is Becton Dickinson stock price today?
The current price of BDX is $201.91 USD — it has decreased by -0.77% in the past 24 hours. Watch Becton Dickinson stock price performance more closely on the chart.
What is Becton Dickinson stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Becton Dickinson stocks are traded under the ticker BDX.
Is Becton Dickinson stock price growing?
BDX stock has fallen by -0.74% compared to the previous week, the month change is a +3.58% rise, over the last year Becton Dickinson has showed a -18.45% decrease.
What is Becton Dickinson market cap?
Today Becton Dickinson has the market capitalization of 57.63B
When is the next Becton Dickinson earnings date?
Becton Dickinson is going to release the next earnings report on February 09, 2026.
What were Becton Dickinson earnings last quarter?
BDX earnings for the last quarter are 3.96 USD per share, whereas the estimation was 3.92 USD resulting in a +1.05% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Becton Dickinson revenue for the last year?
Becton Dickinson revenue for the last year amounts to 43.68B USD.
What is Becton Dickinson net income for the last year?
BDX net income for the last year is 3.36B USD.
Does Becton Dickinson pay dividends?
Yes, BDX dividends are paid quarterly. The last dividend per share was 1.05 USD. As of today, Dividend Yield (FWD)% is 2.06%.
How many employees does Becton Dickinson have?
As of February 02, 2026, the company has 70,000 employees.
In which sector is Becton Dickinson located?
Becton Dickinson operates in the Health Care sector.
When did Becton Dickinson complete a stock split?
Becton Dickinson has not had any recent stock splits.
Where is Becton Dickinson headquartered?
Becton Dickinson is headquartered in Franklin Lakes, US.